Cancer Research AACR Membership  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Published online first on June 30, 2009
[Cancer Research, 10.1158/0008-5472.CAN-09-0244]
This Article
Right arrow Full Text (Online First [PDF])
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-09-0244v1
69/14/5978    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Bon, G.
Right arrow Articles by Falcioni, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bon, G.
Right arrow Articles by Falcioni, R.

Molecular Biology, Pathobiology, and Genetics

Negative Regulation of {beta}4 Integrin Transcription by Homeodomain-Interacting Protein Kinase 2 and p53 Impairs Tumor Progression

Giulia Bon 1, Selene E. Di Carlo 1, Valentina Folgiero 1, Paolo Avetrani 2, Chiara Lazzari 1, Gabriella D'Orazi 3, Maria Felice Brizzi 4, Ada Sacchi 1, Silvia Soddu 1, Giovanni Blandino 1, Marcella Mottolese 2, and Rita Falcioni 1*

1Molecular Oncogenesis Laboratory, Department of Experimental Oncology, and 2Department of Pathology, Regina Elena Cancer Institute, Rome, Italy; 3Department of Oncology and Neurosciences, University of Chieti, Chieti, Italy; and 4Department of Internal Medicine, University of Turin, Turin, Italy

* To whom correspondence should be addressed. E-mail: falcioni{at}ifo.it.


   Abstract

Increased expression of {alpha}6{beta}4 integrin in several epithelial cancers promotes tumor progression; however, the mechanism underlying its transcriptional regulation remains unclear. Here, we show that depletion of homeodomain-interacting protein kinase 2 (HIPK2) activates {beta}4 transcription that results in a strong increase of {beta}4-dependent mitogen-activated protein kinase and Akt phosphorylation, anchorage-independent growth, and invasion. In contrast, stabilization of HIPK2 represses {beta}4 expression in wild-type p53 (wtp53)-expressing cells but not in p53-null cells or cells expressing mutant p53, indicating that HIPK2 requires a wtp53 to inhibit {beta}4 transcription. Consistent with our in vitro findings, a strong correlation between {beta}4 overexpression and HIPK2 inactivation by cytoplasmic relocalization was observed in wtp53-expressing human breast carcinomas. Under loss of function of HIPK2 or p53, the p53 family members TAp63 and TAp73 strongly activate {beta}4 transcription. These data, by revealing that {beta}4 expression is transcriptionally repressed in tumors by HIPK2 and p53 to impair {beta}4-dependent tumor progression, suggest that loss of p53 function favors the formation of coactivator complex with the TA members of the p53 family to allow {beta}4 transcription. [Cancer Res 2009;69(14):5978–86]

Key Words: integrin {alpha}6{beta}4, HIPK2, p53 family members, transcription, tumor progression







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.